Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Science Data

Science Data

Data collected about science.

The EDRN is involved in researching hundreds of biomarkers. The following is a partial list of associated results from biomarker research that are currently available for access and viewing. The bioinformatics team at EDRN is currently working with EDRN collaborative groups to capture, curate, review and post additional data as it is available. EDRN also provides secure access to additional biomarker information not available to the public that is currently under review by EDRN research groups. If you have access to this information, please ensure that you are logged in. If you are unsure or would like access, please contact the operator for more information.

Contents

Title PI(s) Organ Protocol Collaborative Group
Reproducibility of miRNA Measurements Plant, Anne Development of reference samples and interlaboratory testing to improve the confidence in the measurement of microRNAs Lung and Upper Aerodigestive
Analysis of pancreatic cancer biomarkers in PLCO set Lokshin, Anna Biomarkers for early detection of pancreatic cancer GI
Autoantibody Biomarkers Hanash, Samir Validation of Protein Markers for Lung Cancer Using CARET Sera and Proteomics Techniques Lung and Upper Aerodigestive
BCCA_Affy6.0RawData Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
Barrett's Esophagus Methylation Profile Dataset Meltzer, Stephen Barrett's Esophagus Methylation Profiles GI and Other Associated
COPY_NUMBER_LEV1 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
COPY_NUMBER_LEV2 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
COPY_NUMBER_LEV3 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
DNA_METHYLATION_LEV1 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
DNA_METHYLATION_LEV2 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
DNA_METHYLATION_LEV3 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
Duke University Breast Data Marks, Jeffrey Expression based markers for breast cancer detection Breast/GYN
EDRN Prostate Data University of Washington Liu, Alvin Y. Biomarkers for Prostate and Bladder Cancer Prostate and Urologic
EDRN WHI Colon Fred Hutchinson Cancer Research Center Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Harvard University Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Johns Hopkins Medical Institution Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Karmanos Cancer Institute Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Northeastern University Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Pacific National Northwest Laboratory Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon University of Michigan Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon University of Pittsburgh Cancer Institute Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EDRN WHI Colon Wistar Hanash, Samir EDRN-WHI Pre-Clinical Colon Ca Specimens Prostate and Urologic
EVMS Mass Spec Data Semmes, John SELDI Phase I: Assay Validation-Prostate Prostate and Urologic
FHCRC MALDI Dilution Processed Data Feng, Ziding MALDI Dilution Data: Randolph Prostate and Urologic
FHCRC Proteomics Analyzed Data Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
FHCRC Tewari Controls Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
FHCRC Tewari Efficiencies Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
FHCRC Tewari Raw Cp All Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
FHCRC Tewari Raw Cp below No Enz RT Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
GENE_EXPRESSION_LEV1 Gazdar, Adi Identification of biomarkers for lung cancer in never smokers Lung and Upper Aerodigestive
New Funding Opportunity: Biomarker Development Laboratories for the Early Detection Network: Applications Due May 23

Update: Pre-application webinar information now available.

The National Cancer Institute's Division of Cancer Prevention has released a new funding opportunity to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units of the recently funded Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. BDLs are responsible for the discovery, development, characterization, and testing of new, or the refinement of existing, biomarkers and biomarker assays for risk assessment, detection, and molecular diagnosis and prognosis of cancers.

The existing BDLs are primarily focused on ovary and gastrointestinal cancers. The proposed BDLs (to be supported under this funding opportunity) should be focused on one or more of the following cancers: breast, prostate and other genitourinary organs, or lung. In addition, cancers with rapidly rising incidence rates, e.g., endometrial, hepatocellular, kidney, thyroid, oropharyngeal cancers, and/or cancers with unique etiology, e.g., mesothelioma, will be considered.

The newly funded units of the Early Detection Research Network will be announced later in April. Successful applicants have already been notified. Those researchers who were not successful during the last round of applications are encouraged to apply to this opportunity.